Buprenorphine And Naloxone
Product Images NDC 53217-138

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Buprenorphine And Naloxone (NDC 53217-138). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aidarex Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Buprenorphine Hydrochloride)

Chemical Structure (Buprenorphine Hydrochloride)
HCI refers to Human-Computer Interaction which is a field of study that focuses on the design, evaluation, and implementation of interactive computing systems for human use. It involves understanding how people interact with technology and developing user interfaces that are easy to use and efficient. HCI plays a crucial role in the development of technologies such as mobile apps, websites, and software applications.*
FDA Label Image

Chemical Structure (Naloxone Hydrochloride Dihydrate)

FDA Label Image

Figure 3 (Buprenorphine Naxalone 3)

FDA Label Image

Packaged Label (Buprenorphine Naxalone 4)

Packaged Label (Buprenorphine Naxalone 4)
This is a description of a medication packaging for Buprenorphine and Naloxone sublingual tablets, generic for Suboxen. The tablets are round, white, and have "NG" imprinted on one side and a manufacturer logo on the reverse. The package contains 30 tablets with a strength of 8/2mg. The tablets contain Buprenorphine and Naloxone as active ingredients. The medication is required to be stored in a controlled environment at a temperature of 2025 (8777). The packaging includes various codes like RX, NDC, and INS, which are for reference purposes only. The medication is dispensed only with a prescription, and the packaging cautions to keep it out of reach of children. The packaging was manufactured by ETHYPHARMA S.A., France.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.